Jacqueline J Jervis, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 281 Seaside Ave, Milford, CT 06460 Phone: 203-878-9718 |
Ms. Julie Ping Gedalecia, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2044 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-1006 Fax: 203-878-7043 |
Ms. Page Renee Burns, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 40 Bertrose Ave, Milford, CT 06460 Phone: 860-449-3785 |
Leah Finch, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 233 Broad St, Milford, CT 06460 Phone: 860-810-4151 |
Jean-luc G Sebabi, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 300 Seaside Ave, Milford, CT 06460 Phone: 203-876-4000 |
Mr. Joseph Anthony Salzillo, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 849 Boston Post Rd, Suite 201, Milford, CT 06460 Phone: 203-876-7533 |
Jennifer Ann Fisher, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20 Commerce Park, Milford, CT 06460 Phone: 203-301-5860 Fax: 203-301-5861 |
News Archive
A research team led by Brigham and Women's Hospital and Dana-Farber Cancer Institute has uncovered surprising new findings that underscore the role of an important signaling pathway, already known to be critical in cancer, in the development of type 2 diabetes.
New research has shown that the manipulation of a single gene in female fruit flies can make their sexual behavior resemble that of males, in a study that demonstrates the power of individual genes and the profound impact of genetics on complex sexual behavior.
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company, today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma Gene Expression Classifier to be offered to patients in the state.
Microchip Technology Inc., a leading provider of microcontroller and analog semiconductors, today announced a new Medical Design Partner Specialist. TechEn, Inc. joins Microchip's program of more than 14 Design Partner Specialists in areas such as medical electronics, Radio-Frequency (RF) design and touch sensing.
Bowel (colorectal) cancer is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women worldwide. The global burden is expected to increase by 60 per cent to more than 2.2 million new cases and 1.1 million deaths by 2030.
› Verified 2 days ago